The annual summit for research institution gap fund and accelerator programs, including proof of concept programs, startup accelerators, and university venture funds
Oxford University was an early investor in OrganOx, supporting the company with proof-of-concept funding via the University Challenge Seed Fund and investing further through the Spinout Equity Management Fund.
Full story: Oxford University spinout OrganOx to be acquired by Terumo for a record $1.5bn | University of Oxford
The Consortium provides a dedicated, institutional coordinating forum for collective insight, program refinement, and structured engagement with aligned commercial, investment, and philanthropic partners.
GAP are an interdependent institutional innovation and capital strategy that includes:
Translational research
Proof of concept programs
Startup accelerators
University venture funds
